1 / 5

Danone To Rationalize Its Product Porfolio For Accelerated Growth In India

Danone has a stated goal to double its nutrition business in India by 2020 in line with its global mission to ‘bring health through food to as many people as possible’ and this renewed focus is key to achieving this goal.

Danoneindia
Download Presentation

Danone To Rationalize Its Product Porfolio For Accelerated Growth In India

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. DANONE TO RATIONALIZE ITS PRODUCT PORTFOLIO FOR ACCELERATED GROWTH IN INDIA

  2. 11 Jan 2018 Mumbai: January 11, 2018 Danone has decided to rationalize its product portfolio in India to allow for accelerated investments and a sharper focus on growing its nutrition portfolio which is more than 90% of the business, and where the company already enjoys leadership position. In line with this, Danone with discontinue SKU’s which have been making a minority contribution to its overall business in India which include the UHT and fresh dairy products. Danone has a stated goal to double its nutrition business in India by 2020 in line with its global mission to ‘bring health through food to as many people as possible’ and this renewed focus is key to achieving this goal.

  3. According to Danone India Spokesperson: “We have great ambitions for our business in India and remain committed to invest and grow in India through well-established brands such as Protinex, Aptamil, Farex, Dexolac and Neocate. In order to maximize growth opportunities, we are continuously analyzing our portfolio and sharpening our focus to accelerate investments on the best performing categories and products. For this reason, we will discontinue some of the SKU’s sold in India”

  4. “Our focus is to bring nutritionally superior and relevant products to India, and 2017 has been a testimony of that with 10 new launches including some from our global portfolio.” In line with this, a small factory at Rai near Delhi manufacturing discontinued products will stop production. Danone’s state-of-the art factory at Lalru involved in manufacturing the infant nutrition products will continue to function as usual.

  5. Thank You

More Related